Company Filing History:
Years Active: 2004
Title: The Innovations of Peter Wr Caulkett
Introduction
Peter Wr Caulkett is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic and anticoagulant agents. His work has implications for the treatment of various medical conditions in humans and animals.
Latest Patents
Peter Wr Caulkett holds a patent for "Heterocyclic derivatives which inhibit factor Xa." This invention relates to heterocyclic derivatives of formula (I), or pharmaceutically-acceptable salts thereof, which possess antithrombotic and anticoagulant properties. These compounds are useful in methods of treatment for both humans and animals. The patent also covers processes for the preparation of these heterocyclic derivatives, pharmaceutical compositions containing them, and their use in the manufacture of medicaments aimed at producing an antithrombotic or anticoagulant effect. He has 1 patent to his name.
Career Highlights
Peter is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in healthcare, particularly in the area of blood coagulation and related disorders.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues, including Roger James and Stuart Eric Pearson. These collaborations have further enhanced the impact of his research and innovations in the pharmaceutical industry.
Conclusion
Peter Wr Caulkett's contributions to the field of pharmaceuticals, particularly through his patent on heterocyclic derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.